Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Dentistry
Volume 2014, Article ID 860804, 5 pages
http://dx.doi.org/10.1155/2014/860804
Case Report

Severe Periodontal Disease Associated with Long-Term Treatment with Intravenous Immunoglobulin

1Department of Oral Surgery and Pathology, School of Dentistry, Federal University of Minas Gerais, 31270-901 Belo Horizonte, MG, Brazil
2Special Service for Diagnosis and Treatment in Dentistry (SEDTO), Hospital and Clinics, Federal University of Minas Gerais, 30130-100 Belo Horizonte, MG, Brazil
3Department of Community and Preventive Dentistry, School of Dentistry, Federal University of Minas Gerais, 31270-901 Belo Horizonte, MG, Brazil
4Department of Biological Sciences, Bauru School of Dentistry, University of São Paulo, 17012-901 Bauru, SP, Brazil
5Neurology Service, Hospital and Clinics, Federal University of Minas Gerais, 30130-100 Belo Horizonte, MG, Brazil

Received 8 July 2014; Accepted 18 September 2014; Published 15 October 2014

Academic Editor: Márta Radnai

Copyright © 2014 Jôice Dias Corrêa et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. M. Van Den Berg-Vos, H. Franssen, J. H. J. Wokke, and L. H. Van Den Berg, “Multifocal motor neuropathy: long-term clinical and electrophysiological assessment of intravenous immunoglobulin maintenance treatment,” Brain, vol. 125, no. 8, pp. 1875–1886, 2002. View at Publisher · View at Google Scholar · View at Scopus
  2. V. H. Lawson and W. D. Arnold, “Multifocal motor neuropathy: a review of pathogenesis, diagnosis, and treatment,” Neuropsychiatric Disease and Treatment, vol. 10, pp. 567–576, 2014. View at Publisher · View at Google Scholar · View at Scopus
  3. M. C. Dalakas, “The use of intravenous immunoglobulin in the treatment of autoimmune neuromuscular diseases: Evidence-based indications and safety profile,” Pharmacology and Therapeutics, vol. 102, no. 3, pp. 177–193, 2004. View at Publisher · View at Google Scholar · View at Scopus
  4. H. Orbach, U. Katz, Y. Sherer, and Y. Shoenfeld, “Intravenous immunoglobulin: adverse effects and safe administration,” Clinical Reviews in Allergy and Immunology, vol. 29, no. 3, pp. 173–184, 2005. View at Publisher · View at Google Scholar · View at Scopus
  5. G. C. Armitage, “Development of a classification system for periodontal diseases and conditions,” Annals of Periodontology, vol. 4, no. 1, pp. 1–6, 1999. View at Publisher · View at Google Scholar · View at Scopus
  6. D. F. Kinane and D. F. Lappin, “Immune processes in periodontal disease: a review,” Annals of Periodontology, vol. 7, no. 1, pp. 62–71, 2002. View at Publisher · View at Google Scholar · View at Scopus
  7. G. J. Linden and M. C. Herzberg, “Periodontitis and systemic diseases: a record of discussions of working group 4 of the Joint EFP/AAP Workshop on Periodontitis and Systemic Diseases,” Journal of Clinical Periodontology, vol. 40, no. 14, pp. S20–S23, 2013. View at Publisher · View at Google Scholar · View at Scopus
  8. R. A. Seymour, “Effects of medications on the periodontal tissues in health and disease,” Periodontology 2000, vol. 40, no. 1, pp. 120–129, 2006. View at Publisher · View at Google Scholar · View at Scopus
  9. S. S. Beeraka, K. Natarajan, R. Patil, R. K. Manne, V. S. Prathi, and V. S. K. Kolaparthi, “Clinical and radiological assessment of effects of long-term corticosteroid therapy on oral health,” Journal of Dental Research, vol. 10, no. 5, pp. 666–673, 2013. View at Google Scholar
  10. S. B. Ferreira Jr., A. P. F. Trombone, C. E. Repeke et al., “An interleukin-1β (IL-1β) single-nucleotide polymorphism at position 3954 and red complex periodontopathogens independently and additively modulate the levels of IL-1β in diseased periodontal tissues,” Infection and Immunity, vol. 76, no. 8, pp. 3725–3734, 2008. View at Publisher · View at Google Scholar · View at Scopus
  11. C. E. Repeke, A. P. F. Trombone, S. B. Ferreira Jr. et al., “Strong and persistent microbial and inflammatory stimuli overcome the genetic predisposition to higher matrix metalloproteinase-1 (MMP-1) expression: a mechanistic explanation for the lack of association of MMP1-1607 single-nucleotide polymorphism genotyp,” Journal of Clinical Periodontology, vol. 36, no. 9, pp. 726–738, 2009. View at Publisher · View at Google Scholar · View at Scopus
  12. Y.-M. Wu, J. Yan, L.-L. Chen, W.-L. Sun, and Z.-Y. Gu, “Infection frequency of Epstein-Barr virus in subgingival samples from patients with different periodontal status and its correlation with clinical parameters,” Journal of Zhejiang University Science B., vol. 7, no. 11, pp. 876–883, 2006. View at Publisher · View at Google Scholar · View at Scopus
  13. A. Vitória Imbronito, O. S. Okuda, N. M. De Freitas, R. F. M. Lotufo, and F. D. Nunes, “Detection of herpesviruses and periodontal pathogens in subgingival plaque of patients with chronic periodontitis, generalized aggressive periodontitis, or gingivitis,” Journal of Periodontology, vol. 79, no. 12, pp. 2313–2321, 2008. View at Publisher · View at Google Scholar · View at Scopus
  14. N. K. Spurlock and J. E. Prittie, “A review of current indications, adverse effects, and administration recommendations for intravenous immunoglobulin,” Journal of Veterinary Emergency and Critical Care, vol. 21, no. 5, pp. 471–483, 2011. View at Publisher · View at Google Scholar · View at Scopus
  15. G. Hajishengallis, “Complement and periodontitis,” Biochemical Pharmacology, vol. 80, no. 12, pp. 1992–2001, 2010. View at Publisher · View at Google Scholar · View at Scopus
  16. J. L. Krauss, J. Potempa, J. D. Lambris, and G. Hajishengallis, “Complementary Tolls in the periodontium: How periodontal bacteria modify complement and Toll-like receptor responses to prevail in the host,” Periodontology 2000, vol. 52, no. 1, pp. 141–162, 2010. View at Publisher · View at Google Scholar · View at Scopus
  17. M. Seeling, U. Hillenhoff, J. P. David et al., “Inflammatory monocytes and Fcγ receptor IV on osteoclasts are critical for bone destruction during inflammatory arthritis in mice,” Proceedings of the National Academy of Sciences of the United States of America, vol. 110, no. 26, pp. 10729–10734, 2013. View at Publisher · View at Google Scholar · View at Scopus